These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11400938)

  • 1. Normal midtrimester (17-20 weeks) genetic sonogram decreases amniocentesis rate in a high-risk population.
    Pinette MG; Garrett J; Salvo A; Blackstone J; Pinette SG; Boutin N; Cartin A
    J Ultrasound Med; 2001 Jun; 20(6):639-44. PubMed ID: 11400938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
    Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA
    Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is genetic ultrasound cost-effective?
    DeVore GR
    Semin Perinatol; 2003 Apr; 27(2):173-82. PubMed ID: 12769203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.
    DeVore GR; Romero R
    J Ultrasound Med; 2001 Jun; 20(6):645-54. PubMed ID: 11400939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results.
    DeVore GR; Romero R
    J Ultrasound Med; 2003 Nov; 22(11):1191-9. PubMed ID: 14620890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome.
    Yeo L; Vintzileos AM
    Semin Perinatol; 2003 Apr; 27(2):152-9. PubMed ID: 12769201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen.
    Vintzileos AM; Guzman ER; Smulian JC; Yeo L; Scorza WE; Knuppel RA
    Obstet Gynecol; 2002 Jun; 99(6):993-5. PubMed ID: 12052588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
    Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome risk estimation after normal genetic sonography.
    Vintzileos AM; Guzman ER; Smulian JC; Yeo L; Scorza WE; Knuppel RA
    Am J Obstet Gynecol; 2002 Nov; 187(5):1226-9. PubMed ID: 12439509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second trimester ultrasound screening for chromosomal abnormalities.
    Shipp TD; Benacerraf BR
    Prenat Diagn; 2002 Apr; 22(4):296-307. PubMed ID: 11981910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
    Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
    Benn PA; Horne D; Briganti S; Greenstein RM
    Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
    Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L
    Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of second-trimester genetic sonogram for detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; McLean DA; Ananth CV
    Obstet Gynecol; 1997 Aug; 90(2):187-90. PubMed ID: 9241290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound screening of fetuses at increased risk for Down syndrome: how many missed diagnoses?
    Caughey AB; Lyell DJ; Washington AE; Filly RA; Norton ME
    Prenat Diagn; 2006 Jan; 26(1):22-7. PubMed ID: 16378329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the association of a serum marker and second trimester ultrasonography for the screening of trisomy 21 in women of less than 38 years. Prospective study of 5,163 patients].
    Lefebvre G; Vauthier-Brouzes D; Choukroun JB; Sebagh E; Bernard M; Brochet C; Lesourd S; Darbois Y
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(6):599-604. PubMed ID: 9854223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.